Health TrialsbyHealthPanel

Text Education About Cardiovascular Health and HIV (TEACH-HIV)

ConditionsHIVHuman Immunodeficiency VirusCardiovascular DiseasesAtherosclerosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorUniversity of California, San Francisco

About this trial

The overall objective is to evaluate the efficacy of educational text messages to reduce cardiovascular risk among persons living with HIV (PLWH).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

HIV positive

At least 40 years of age

English-speaking

Disqualifiers

Existing clinical atherosclerotic cardiovascular disease (ASCVD)

Pregnant

Unwilling/unable to provide informed consent

Does not own a smartphone

Trial design

Design model

Parallel

Treatments tested in this trial

  • Digital Educational Messaging

    Behavioral

    Education via mobile phone text messages for up to 6 months.

Treatment groups

260 Participants
are divided into 2 treatment groups
Group A: Intervention ArmExperimental treatment 1 intervention
Group B: Control ArmNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Proportion of participants with controlled blood pressure

Proportion of participants with blood pressure \< 130/80 mmHg as recorded in the electronic health record (EHR).

Time frame
6 months

Secondary outcomes

1

Number of cardiovascular risk factors controlled

Total of 8 risk factors: diet, physical activity, nicotine exposure, sleep health, body mass index, blood lipids, blood glucose, blood pressure. Risk factors will be assessed using self-report and EHR data. Risk factor control will be defined based on the American Heart Association's (AHA) Life's Essential 8.

Time frame
6 months
2

Self-perceived cardiovascular risk

Measured by self-report using questions adapted from the patient and provider assessment of lipid management (PALM) registry.

Time frame
6 months
3

Systolic blood pressure

Evaluated using EHR data.

Time frame
6 months
4

Cholesterol

Non-HDL cholesterol, total cholesterol, LDL cholesterol (in mg/dL), as evaluated using EHR data.

Time frame
6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of California, San Francisco

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Source ClinicalTrials.gov
Apply now